Zoetis Inc.

US$79.40As of Sun 8 Nov 2026, 12:00 UTC
NYSE:ZTSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 6.19%
Div yield 2.67%
ROE 57.63%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.68
PE TTM 13.40
TSR TTM (43.65%)
Mkt cap US$32.26B
ROIC 26.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$80
0.82%
(53.13%)
Hold 10|0|5|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.96
0.94
0.97
1.05
27.05%
18.62%
11.99%
12.79%
Revenue$B
2.543
2.646
2.782
2.903
9.54%
12.36%
11.84%
17.12%
Peers (US$32.26B)
Cap (US$)
PE
23.94B
21.18x
22.83B
—
29.17B
81.44x
Capital
TTM
5Y
10Y
Leveragex
0.917
(0.173)
(0.167)
EBIT/Intx
0.856
0.167
0.148
Own earn%
(346.31)
49.35
62.51
Sh yield%
22.80
28.96
25.74
Owners
Insiders/Inst%
11.71
88.96
Short interest%
1.21
SBC / revenue%
3.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–16
$1 testx
—
Incr. ROIC%
10